Transcatheter closure of patent arterial duct with amplatzer duct occluder II additional sizes in children.

Amplatzer duct occluder II additional sizes is a new generation of device for arterial duct closure, appropriate for infants and older children. We report the successful transcatheter closure of the arterial duct in an infant and two older children with the above-mentioned device.

Kawasaki disease in Greek children: a retrospective study.

Background: The studies of series of children with Kawasaki disease (KD) in Greek children are limited.

Objectives: To evaluate the epidemiology, clinical manifestations, laboratory findings, course and outcome of complete KD in Greek children.

Methods: Patients with complete KD who were discharged from our hospital and followed up routinely between 2004 and 2011 were included in the study.

Eighteen months' experience with remote diagnosis, management and education in congenital heart disease.

In July 1998, a telemedicine link was established between the Venizelio General Hospital in Crete and the Paediatric Cardiology Department of the Aghia Sophia Children's Hospital in Athens. The telemedicine link used ISDN at 384 kbit/s for diagnosis, management and education in congenital heart disease. Over 18 months, a total of 39 teleconsultations were carried out, concerning 93 children with haemodynamically significant cardiac abnormalities.

Closure of atrial septal defects with the Amplatzer occlusion device: preliminary results.

Objectives: This study reports our clinical experience with transcatheter closure of secundum atrial septal defects (ASDs) in children, using the Amplatzer, a new occlusion device.

Background: None of the devices previously used for transcatheter closure of interatrial communications has gained wide acceptance.

Methods: We examined the efficacy and safety of the Amplatzer, a new self-centering septal occluder that consists of two round disks made of Nitinol wire mesh and linked together by a short connecting waist.